Abstract
Background: Alcohol is one of the main contributors to diseases world-wide which leads to a potentially preventable death. Alcohol use disorders are the most prevalent of all substance use disorders. Alcohol dependence poses physical, psychological, economic and social issues to the individual, families and community. Objectives: To assess the effectiveness of Nux Vomica 1M in reducing the craving for alcohol in dependent subjects.Materials and Methods: Cases presenting with Alcohol dependence are assessed with Penn Alcohol Craving Scale (PACS) and Severity of Alcohol Dependence Questionnaire (SADQ) for craving and dependence respectively. Nux vomica 1M was given orally twice a day for 8 weeks. The data obtained from the pre and post treatment was statistically analyzed. Results: Paired sample t test showed that there is a statistically significant difference between the before and after PACS scores (t=9.55, df=29, p< 0.001) with a mean difference of 7.77±0.81(95%CI: 6.10to 9.43). The before and after scores of SADQ were significantly different (t=8.94, df=29, p
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
